Beyond Botox: Can Electrical Stimulation Ease Post-Stroke Spasticity and Pain?
"A combined approach offers hope for improved quality of life and function for stroke survivors."
Surviving a stroke is often just the beginning of a long journey toward recovery. Many stroke survivors face lasting challenges, including spasticity (muscle stiffness) and chronic pain, which can significantly impact their ability to perform everyday tasks and enjoy a good quality of life.
Botulinum neurotoxin type A (BoNTA), commonly known as Botox, has become a popular treatment for managing spasticity by relaxing targeted muscles. However, a promising complementary therapy, functional electrical stimulation (FES), is also gaining traction in rehabilitation. FES uses mild electrical pulses to stimulate muscles, helping to improve their function and reduce stiffness.
Now, researchers are exploring whether combining BoNTA injections with FES can provide even greater benefits for stroke patients struggling with spasticity and pain. This article delves into a recent case study that sheds light on the potential of this combined approach to enhance function and overall well-being after a stroke.
Prevalence and Consequences
The 2026 early-intervention review estimates that spasticity and related motor disorders affect 30% to 80% of stroke survivors. It can impair functional mobility, reduce independence, and increase caregiver burden. A 2021 review identifies a large cluster of people who developed spasticity within 20 months after stroke, particularly those with moderate stroke severity and no hemisensory loss. A World Stroke Organization survey, while small, also highlights gaps in knowledge, information, treatment availability, and access.
Current Care and Its Gaps
Rehabilitation approaches studied for post-stroke spasticity include proprioceptive neuromuscular facilitation and NDT-Bobath, with the modified Ashworth scale used in the cited comparison to assess spasticity. The available literature remains limited, particularly for clinical management and modified Ashworth scale assessment. The 2026 review reports that many patients receive treatment only after spasticity is well established, while others receive none because of disparities in recognition, access, and delivery. Practical Neurology emphasizes that individualized management and early rehabilitation can reduce disability and optimize outcomes.
An Evolving Field
The management of post-stroke spasticity has developed through rehabilitation strategies intended to address abnormal muscle tone and impaired movement. More recent approaches have broadened the discussion to include earlier recognition, individualized therapy, and technologies such as electrical stimulation. The evidence base remains evolving, so historical progress should not be interpreted as proof that any single intervention works for every survivor.
BoNTA and FES: A Synergistic Approach to Stroke Recovery
A recent case study published in Future Neurology highlights the use of BoNTA and FES in a 57-year-old male who experienced right-side upper limb spasticity four years after suffering a stroke. The patient had previously tried baclofen and BoNTA alone, with limited success and bothersome side effects.
- BoNTA Injections: Relaxes targeted muscles by blocking nerve signals, reducing stiffness.
- Functional Electrical Stimulation (FES): Uses electrical pulses to stimulate muscles, improving function and reducing pain.
- Combined Approach: Aims to enhance the benefits of both therapies for improved outcomes.
A Growing Evidence Base
Recent research is increasingly examining how different rehabilitation interventions influence post-stroke spasticity and motor recovery. Studies have investigated physical stimulation, robotic devices, and combinations of rehabilitation techniques, but their aims and outcome measures vary. This makes direct comparison difficult and supports cautious interpretation of claims about electrical stimulation. Larger and more consistent studies are needed to establish which patients benefit most.
Limits and Uncertainty
Spasticity is only one component of upper motor neurone syndrome; weakness, disordered motor control, and bladder or bowel dysfunction may also require management. The condition can develop during the first weeks after stroke, yet it is mostly treated in the chronic phase. A 2024 study found that botulinum toxin applied within three months effectively reduced spasticity and suggested that electrical stimulation may also reduce it, but the wording indicates a promising possibility rather than definitive evidence. Research also remains limited on how spasticity interacts with proprioception and affects rehabilitation outcomes.
Comparing Rehabilitation Modalities
Comparative studies are evaluating a range of interventions rather than treating electrical stimulation as a standalone solution. One 2024 study compared tendon and muscle-belly vibratory stimulation for reducing spasticity in the finger and wrist flexors after stroke. A 2025 network meta-analysis compared 21 intervention modalities for upper-limb spasticity, with the stated goal of informing personalized, multimodal rehabilitation. Other research has examined rTMS combined with physiotherapy and compared PNF with NDT-Bobath, reflecting the field's emphasis on tailored combinations and varied measurement methods.
Hope for Improved Stroke Recovery
This case study offers a promising glimpse into the potential of combining BoNTA and FES to improve the lives of stroke survivors struggling with spasticity and pain. While more research is needed, this approach could significantly enhance functional abilities and overall quality of life.
Early, Individualized Intervention
The available sources agree that post-stroke spasticity is common, potentially disabling, and associated with reduced mobility, independence, and greater caregiver burden. They also indicate that spasticity may arise in the first weeks after stroke even though treatment is often delivered later in the chronic phase. Early botulinum toxin treatment within three months has been reported to reduce spasticity, while electrical stimulation is described as a potentially useful intervention that still requires further study. The practical implication is that assessment and treatment timing should be individualized rather than postponed until impairment is firmly established.
Toward More Targeted Care
Future work may focus on identifying which stroke survivors are most likely to benefit from electrical stimulation and when treatment should begin. Combining stimulation with rehabilitation, rather than evaluating it in isolation, may help researchers assess effects on both tone and function. Progress will depend on clearer outcome measures, better comparisons between modalities, and studies that reflect real-world rehabilitation settings.
Access Shapes Outcomes
The impact of post-stroke spasticity is shaped not only by biological impairment but also by whether people are recognized, referred, and able to obtain appropriate rehabilitation. Differences in access to clinicians, therapy, and follow-up can affect the treatments people receive and the timing of those treatments. A broader response therefore requires attention to service delivery and continuity of care alongside technological innovation.
Function Beyond Muscle Tone
Real-world rehabilitation aims to improve movement, function, and satisfaction rather than simply change a spasticity score. A 2026 study is evaluating the robotic device RYMO, also called Mobi-L, for spasticity management, motor-function recovery, and subjective satisfaction in people with chronic stroke. Another longitudinal observational study is examining how botulinum toxin timing, physical therapy, pharmacological therapies, and comorbidities relate to upper-limb spasticity outcomes. A case report describes conventional physiotherapy as producing moderate results while linking spasticity with impaired motor control and functional limitations.
Further studies with larger groups of patients are necessary to determine the optimal combination of BoNTA dosage and FES parameters, as well as to identify which patients are most likely to benefit from this combined therapy. Understanding the underlying mechanisms that make this combined approach effective is also crucial.
Ultimately, continued research in this area could lead to more effective and personalized rehabilitation strategies, helping stroke survivors regain independence, reduce pain, and improve their overall well-being.